Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects
Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects have?
Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects has 42 citations in the OpenAlex counts ScholarIQ stores.
When was Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects published?
Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects has 2015 year in the ScholarIQ index.
What is the open-access status of Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects?
Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects has hybrid oa status in the ScholarIQ index.
What is the DOI of Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects?
The DOI for Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects is on the source record.
What is the PMID of Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects?
The PMID for Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects is on the source record.
What is the OpenAlex record for Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects?
The OpenAlex for Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects is on the source record.